Apo-fluoxetine: The Impurities Are Out Of Specification And Out Of Trend
Apo-Fluoxetine Recall Summary Apo-Fluoxetine tablets are being recalled in Canada because they contain impurities that exceed acceptable limits and show an unusual pattern. This is a Class III recall, which means the product is unlikely to cause serious health problems but still poses a potential safety concern. The recall affects Apo-Fluoxetine products distributed across Canada.
- Product
- Apo-Fluoxetine
- Reason
- Product safety concern
- Classification
- Class III
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-04-10
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/87884caa-da3c-4f2e-8e2a-95a3ae0e9982